Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Rdy | History Defined

Dr. Reddy's Laboratories Q4 Earnings Call Highlights

Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026 performance, with record annual revenue despite pressure from lower lenalidomide sales and several one-time charges during the fourth quarter. Narasimham said the company’s und

MarketBeat

Save money on a new gaming PC in iBUYPOWER's Memorial Day sale

Check out these deals from iBUYPOWER on a range of their RDY prebuilt gaming PCs in their Memorial Day sales event.

Tom’s Hardware

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

StockNews.com

Pharma Watchlist: 3 Stocks Worth Adding

The pharma industry embraces digital trends and advancements in clinical research in 2024, with prospects of significant expansion. Hence, fundamentally strong pharma stocks Dr. Reddy's Laboratories (RDY), Amneal Pharmaceuticals (AMRX), and AbbVie (ABBV) might be worth adding to one’s watchlist. Read more….

StockNews.com

3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio

The pharmaceutical sector is booming with increasing global healthcare demands and technological progress. Hence, top-rated pharma stocks Dr. Reddy’s (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might be solid additions to one’s portfolio in November. Read more.

StockNews.com

3 Pharma Stocks With Market Impact to Consider Buying

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited (HZNP), Dr. Reddy’s Laboratories (RDY), and Novartis (NVS) are better investments right now. Read on.

StockNews.com

3 Pharma Stocks to Consider Prescribing to for Quality

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Given the solid long-term prospects of the industry, investors should consider buying quality stocks, Johnson & Johnson (JNJ), AstraZeneca (AZN), and Dr. Reddy’s Laboratories (RDY). Read on.

StockNews.com

3 Pharma Stocks With Promising Pipelines

The pharma industry is anticipated to stay buoyed in the years to come with consistent medical breakthroughs and rising need to serve an aging population. Therefore, pharma stocks Johnson & Johnson (JNJ), Novartis AG (NVS), and Dr. Reddy's Laboratories (RDY), which possess promising pipelines, could be wise portfolio additions now.…

StockNews.com

Top 3 Pharma Stocks You Can’t Miss out On

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories (RDY), to your portfolio could prove to be beneficial. Read…

StockNews.com

Dr. Reddy's Laboratories (RDY) Is the Pharmaceutical Stock to Buy

Dr. Reddy's Laboratories (RDY) delivered exceptional performance, as its fourth-quarter profits grew by an astonishing eleven-fold. By deftly expanding its product line-up and fortifying its market presence, the company sets the stage for significant growth, which could establish it as the go-to pharmaceutical stock to invest in. Read more….

StockNews.com

Adidas Terrex WMN Mid rain.RDY Hiking Shoes review: stylish, supportive outdoor footwear for women

Down with ugly, beige hiking boots!

Adidas Terrex Multi RAIN.RDY 2.5-Layer Rain Jacket review: breathable waterproof shell for women

This waterproof jacket allows you to breathe, move, stay dry and look stylish, all at the same time

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Growth: These 3 Stocks Continue to Grow as April 2023 Nears an End

While inflation has been declining, rising fears of a recession as a result of the recent financial crisis are expected to put the stock market under pressure. Fundamentally strong stocks, such as Fast Retailing (FRCOY), Dr. Reddy’s (RDY), and Potbelly (PBPB), which look positioned for steady growth despite the headwinds,…

StockNews.com

4 Under-the-Radar Stocks to Buy Before Wall Street Catches On

With the Fed hiking the benchmark interest to the highest in 15 years, the stock market plunged significantly last year. However, the market is expected to rebound in 2023. So, it could be worth betting on under-the-radar stocks Dr. Reddy’s Laboratories (RDY), Berry Global (BERY), Aaron’s Company (AAN), and Karat…

StockNews.com

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

Benzinga

Eton Pharma Shares Tick Higher After Offloading Hospital Products

Eton Pharmaceuticals Inc (NASDAQ:ETON) has sold its hospital products to Dr. Reddy's Laboratories SA, a subsidiary of Dr. Reddy's Laboratories Ltd (NYSE:RDY), for $50 million. "The sale of our hospital products allows us to focus our resources on our core rare disease business, which is rapidly growing, and also provides an attractive opportunity to monetize…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Buy the Dip: 3 Oversold Healthcare Stocks

The healthcare industry has been in the limelight since the onset of the COVID-19 pandemic. The industry has seen a significant shift towards digital care, which could prove permanent and drive growth. Furthermore, with healthcare companies focusing on advanced technologies and innovations, the industry should keep thriving. So, we think…

StockNews.com

Trading Near 52-Week Lows: Grab These 5 Undervalued Healthcare Stocks Now

Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple of months. But given the near-inelastic demand for healthcare solutions and the industry’s long-term growth prospects, we think…

Benzinga

NYSE-Listed Pharma Co. Dr. Reddy's To Acquire German Medical Cannabis Firm Nimbus Health GmbH

Pharmaceutical company Dr. Reddy's Laboratories Ltd. (NYSE:RDY) has entered into a definitive agreement to acquire Nimbus Health GmbH, a medical cannabis-focused licensed pharmaceutical wholesaler from Germany. Under the agreement, Dr.

StockNews.com

4 Mid-Cap Pharmaceutical Stocks to Buy This Month

Despite supply chain disruptions and labor shortages, the pharma industry is well-positioned to continue growing due to the increasing medical needs of an aging population and advancements in treating chronic diseases. Therefore, amid current market volatility, we believe it could be wise to scoop up shares of quality mid-cap pharmaceutical…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.